Health Insurance (1992 Pathology Services Table) Regulations (Amendment)
1992 No. 23
EXPLANATORY STATEMENT
STATUTORY RULES 1992 No. 23
Issued by the authority of the Minister for Health, Housing and Community Services
Health Insurance Act 1973
Health Insurance (1992 Pathology Services Table) Regulations (Amendment)
The Health Insurance Act 1973 (the Act) provides for payments by way of medical benefits, payments for hospital services and payments for matters concerning related committees and tribunals.
Section 133 of the Health Insurance Act 1273 (the Act) provides that the Governor-General may make Regulations, not inconsistent with the Act, prescribing all matters required or permitted by the Act to be prescribed, or necessary or convenient to be prescribed, for carrying out or giving effect to the Act.
Section 4A of the Act provides that the Regulations may prescribe a table of pathology services in accordance with the form of table set out in Schedule 1A and that, upon commencement of a Regulation prescribing a table of pathology services, the prescribed table has effect as if it were set out in Schedule 1A in place of the table in that Schedule. The Health Insurance (1991-1992 Pathology Services Table) Regulations prescribe such a table.
Section 9 of the Act provides, in effect, that medicare benefits shall be calculated by reference to the fees for pathology services set out in the table of pathology services (the table) in Schedule 1A to the Act.
These amendments to the Health Insurance (Pathology Services Table) Regulations limit the payment of medicare benefits for items 73901 to 73921 (inclusive) (for example the items which refer to the costs other than those directly associated with the pathology service) only to circumstances where a medicare benefit is payable for the pathology service which is rendered on the pathology specimen.
These amendments result from major reforms to the practice of pathology announced in the 1991 Budget. The Pathology Advisory Committee. a recently established industry/government body, has endorsed the reforms and recommended the amendments.
The Minister for Health, Housing and Community Services agreed to the amendments, the details of which are set out below, which amended the table of pathology services.
Subregulation 3(1) omits subrule 11(3) in the Rules of Interpretation to the table of pathology services and substitutes a new subrule which requires at least one of the items 65001 to 73529 to apply to the service to enable items 73901 - 73921 to be applicable.
Subregulation 3(3) inserts a new rule 11A into the Rules of Interpretation which provides that where item 73921 is applicable for a patient episode (that is, a specimen referred service) none of the items 73901 - 73917 can apply for that patient episode.
The Regulations came into effect on 1 February 1992.
Overview
The Health Insurance (1992 Pathology Services Table) Regulations (Amendment) 1992 No. 23 was enacted to amend the Health Insurance (Pathology Services Table) Regulations in response to significant reforms in pathology practices as announced in the 1991 Budget. This legislative action was taken under the authority of the Minister for Health, Housing and Community Services and aligns with the provisions of the Health Insurance Act 1973. The primary objective of these amendments was to refine the payment structure for pathology services, specifically addressing the circumstances under which medicare benefits are payable for certain items related to pathology services. The reforms were supported by the Pathology Advisory Committee and reflect a commitment to updating the regulatory framework to better suit current practices and ensure that benefits are appropriately allocated.
These amendments, which came into effect on 1 February 1992, adjust the table of pathology services by limiting the payment of medicare benefits for items 73901 to 73921 to situations where a benefit is payable for the pathology service rendered on the pathology specimen. This change was made to ensure that benefits are only claimed for costs directly associated with the pathology service. The specific amendments include omitting and substituting certain subrules in the Rules of Interpretation to the table of pathology services, thereby ensuring that the regulatory framework is both accurate and reflective of current industry practices.
Scope and Application
The Health Insurance (1992 Pathology Services Table) Regulations (Amendment) 1992 No. 23 apply to the Health Insurance Act 1973 and its provisions concerning payments for medical benefits, hospital services, and related committees and tribunals. These regulations specifically pertain to the table of pathology services, which dictates the fees for which Medicare benefits are calculated. The regulations amend the table to limit the payment of Medicare benefits for certain pathology service items (73901 to 73921) to situations where a benefit is payable for the pathology service rendered on the pathology specimen. This amendment is designed to align with major reforms in pathology practice announced in the 1991 Budget and endorsed by the Pathology Advisory Committee. The amendments came into effect on 1 February 1992 and are applicable to all persons and entities subject to the Health Insurance Act 1973, with no specific exclusions or exemptions noted in the explanatory statement. The regulations extend the application of the Act through the prescribed table, which is integral to determining Medicare benefits.
Key Provisions
The Health Insurance (1992 Pathology Services Table) Regulations (Amendment) 1992 No. 23 amends the Health Insurance (1991-1992 Pathology Services Table) Regulations to adjust the payment of Medicare benefits for specific pathology services. Specifically, Section 3(1) of the amendment omits an existing subrule and introduces a new subrule requiring that at least one of the items 65001 to 73529 must apply to the service for items 73901 to 73921 to be applicable (Health Insurance (1992 Pathology Services Table) Regulations (Amendment) 1992 No. 23, s 3(1)). This means that a Medicare benefit for costs other than those directly associated with the pathology service will only be paid if a pathology service is rendered on the pathology specimen. Furthermore, Section 3(3) introduces a new rule 11A which states that if item 73921 is applicable for a patient episode, none of the items 73901 to 73917 can apply for that patient episode (Health Insurance (1992 Pathology Services Table) Regulations (Amendment) 1992 No. 23, s 3(3)).
These amendments impose specific obligations on healthcare providers and patients. Healthcare providers must ensure that the requirements of the new subrule and rule 11A are met when claiming Medicare benefits for pathology services. This includes verifying that the applicable items 65001 to 73529 are correctly applied to the service before claiming benefits for items 73901 to 73921. Patients, on the other hand, should be aware that the new regulations may affect the scope of benefits they are entitled to receive for certain pathology services. They must ensure that the services rendered meet the criteria specified in the amended table to qualify for the benefits.
Breaching these new regulations can result in significant consequences. The Health Insurance Act 1973 provides for various offences and penalties for non-compliance with its provisions. While the specific penalties are not detailed in the explanatory statement, it is likely that penalties could include fines, recovery of overpaid benefits, and potential legal action. The severity of the penalties may depend on factors such as the intent behind the breach, the extent of the non-compliance, and any harm caused by the breach. Healthcare providers found to be in violation of these regulations could face financial penalties, reputational damage, and possible restrictions on their ability to provide services under the Medicare scheme. For patients, incorrect claims could result in the need to repay any incorrectly received benefits, which could lead to financial hardship. Therefore, adherence to these regulations is crucial for both providers and patients to ensure compliance with Medicare obligations.